Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Barlas

Showing results (21-30 of 149) with videos related to

Pageof 15
Sort By:
Biotechnology Healthcare|February 21, 2013
Biotech steps into the vaccine breachStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|May 4, 2013
Differing views on 'essential health benefits' extend to drug coverage: composition of formularies is a point of contentionStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|September 20, 2013
Key Senator Scrutinizes Pharmacy 340B Selling Practices: Federal Office in Charge of Drug Discounts Begins to Feel the HeatStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|September 12, 2014
New Controversy for 340B: OPA Rebuffs Ruling by CourtStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|August 20, 2014
Are specialty drug prices destroying insurers and hurting consumers?: a number of efforts are under way to reduce price pressureStephen Barlas
Biotechnology Healthcare|April 6, 2012
Pitting the FDA Against CMS: The good, the bad, and the ugly about "parallel review."Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|December 2, 2016
The Push for Additional Orphan Drugs: Can the FDA Do More to Encourage Their Development?Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|December 2, 2016
Prescription Drug Data Might Help Protect Obamacare: Medication Use Will Be Integrated Into Marketplace Plan Risk AdjustmentsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|April 24, 2014
Federal Investigative Report Questions 340B Contract Pharmacy Programs: Office of Pharmacy Affairs Promises Regulatory ResponseStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|March 27, 2014
Specialty pharmacy networks for hospitals in the offing: absence of onsite access to specialty pharmaceuticals has care and financial implicationsStephen Barlas
Pageof 15

Showing results (21-30 of 149) with videos related to

Sort By:
Pageof 15
Biotechnology Healthcare|February 21, 2013
Biotech steps into the vaccine breachStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|May 4, 2013
Differing views on 'essential health benefits' extend to drug coverage: composition of formularies is a point of contentionStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|September 20, 2013
Key Senator Scrutinizes Pharmacy 340B Selling Practices: Federal Office in Charge of Drug Discounts Begins to Feel the HeatStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|September 12, 2014
New Controversy for 340B: OPA Rebuffs Ruling by CourtStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|August 20, 2014
Are specialty drug prices destroying insurers and hurting consumers?: a number of efforts are under way to reduce price pressureStephen Barlas
Biotechnology Healthcare|April 6, 2012
Pitting the FDA Against CMS: The good, the bad, and the ugly about "parallel review."Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|December 2, 2016
The Push for Additional Orphan Drugs: Can the FDA Do More to Encourage Their Development?Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|December 2, 2016
Prescription Drug Data Might Help Protect Obamacare: Medication Use Will Be Integrated Into Marketplace Plan Risk AdjustmentsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|April 24, 2014
Federal Investigative Report Questions 340B Contract Pharmacy Programs: Office of Pharmacy Affairs Promises Regulatory ResponseStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|March 27, 2014
Specialty pharmacy networks for hospitals in the offing: absence of onsite access to specialty pharmaceuticals has care and financial implicationsStephen Barlas
Pageof 15